Allogene Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") (ALLO)

Q: What does CUSIP 019770106 represent in this 13F holders report?

CUSIP 019770106 is the security identifier for ALLO - Allogene Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") used to aggregate holder disclosures.

Q: How many institutions held ALLO - Allogene Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") in Q1 2020?

115 institutional investors reported ALLO - Allogene Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") for Q1 2020. Use the holders table for investor-level position and value details.

CUSIP: 019770106

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class: Equity / Common Stock, par value $0.001 per share (the "Shares")
Shares outstanding: 244,825,714
Total 13F shares: 73,747,853
Share change: +2,108,808
Total reported value: $1,390,700,983
Put/Call ratio: 110%
Price per share: $19.44
Number of holders: 115
Value change: +$46,546,025
Number of buys: 55
Number of sells: 52

Quarterly Holders Quick Answers

What is CUSIP 019770106?
CUSIP 019770106 identifies ALLO - Allogene Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2020
Previous quarter: Q4 2019

Recent filing periods for CUSIP 019770106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ALLO - Allogene Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
TPG Group Holdings (SBS) Advisors, Inc.	13F	Company	8.7%	21,216,306	$551,200,000	—	31 Dec 2019	13F
Capital Research Global Investors	13F	Company	2.7%	6,542,678	$169,979,000	—	31 Dec 2019	13F
BlackRock Finance, Inc.	13F	Company	2.1%	5,024,772	$130,544,000	—	31 Dec 2019	13F
FMR LLC	13F	Company	2%	4,860,966	$126,289,000	—	31 Dec 2019	13F
VANGUARD GROUP INC	13F	Company	1.6%	3,948,293	$102,577,000	—	31 Dec 2019	13F
Capital International Investors	13F	Company	1.6%	3,888,021	$101,011,000	—	31 Dec 2019	13F
Capital World Investors	13F	Company	1.2%	2,977,664	$77,360,000	—	31 Dec 2019	13F
VV Manager LLC	13F	Company	1.2%	2,889,651	$75,073,000	—	31 Dec 2019	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1%	2,470,510	$64,184,000	—	31 Dec 2019	13F
Of The University Of California Regents	13F	Individual	0.96%	2,350,930	$61,077,000	—	31 Dec 2019	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.73%	1,776,303	$46,148,000	—	31 Dec 2019	13F
STATE STREET CORP	13F	Company	0.69%	1,679,450	$43,632,000	—	31 Dec 2019	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.63%	1,543,790	$40,107,000	—	31 Dec 2019	13F
Wildcat Capital Management, LLC	13F	Company	0.49%	1,201,826	$31,223,000	—	31 Dec 2019	13F
Avoro Capital Advisors LLC	13F	Company	0.46%	1,128,594	$29,321,000	—	31 Dec 2019	13F
NORGES BANK	13F	Company	0.43%	1,064,580	$27,658,000	—	31 Dec 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.28%	679,054	$17,641,000	—	31 Dec 2019	13F
Coastal Bridge Advisors, LLC	13F	Company	0.28%	678,839	$17,636,000	—	31 Dec 2019	13F
FRANKLIN RESOURCES INC	13F	Company	0.25%	610,697	$15,866,000	—	31 Dec 2019	13F
NORTHERN TRUST CORP	13F	Company	0.21%	512,000	$13,302,000	—	31 Dec 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.16%	395,447	$10,274,000	—	31 Dec 2019	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.08%	204,312	$5,308,026	—	31 Dec 2019	13F
Marshall Wace North America L.P.	13F	Company	0.08%	193,058	$5,016,000	—	31 Dec 2019	13F
PARTNERS CAPITAL INVESTMENT GROUP, LLP	13F	Company	0.08%	183,750	$4,774,000	—	31 Dec 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.07%	175,134	$4,550,000	—	31 Dec 2019	13F
NORDEA INVESTMENT MANAGEMENT AB	13F	Company	0.07%	171,131	$4,470,000	—	31 Dec 2019	13F
Bank of New York Mellon Corp	13F	Company	0.06%	156,590	$4,068,000	—	31 Dec 2019	13F
MARSHALL WACE, LLP	13F	Company	0.06%	153,105	$3,977,000	—	31 Dec 2019	13F
Nuveen Asset Management, LLC	13F	Company	0.06%	150,795	$3,918,000	—	31 Dec 2019	13F
MACQUARIE GROUP LTD	13F	Company	0.06%	146,779	$3,813,000	—	31 Dec 2019	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.05%	134,413	$3,492,000	—	31 Dec 2019	13F
CREDIT SUISSE AG/	13F	Company	0.05%	129,742	$3,371,000	—	31 Dec 2019	13F
D. E. Shaw & Co., Inc.	13F	Company	0.05%	125,030	$3,248,000	—	31 Dec 2019	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.04%	101,900	$2,647,000	—	31 Dec 2019	13F
JPMORGAN CHASE & CO	13F	Company	0.03%	84,237	$2,188,000	—	31 Dec 2019	13F
HHR Asset Management, LLC	13F	Company	0.03%	80,690	$2,096,000	—	31 Dec 2019	13F
Tekla Capital Management LLC	13F	Company	0.03%	80,280	$2,086,000	—	31 Dec 2019	13F
MORGAN STANLEY	13F	Company	0.03%	80,166	$2,084,000	—	31 Dec 2019	13F
BAINCO INTERNATIONAL INVESTORS	13F	Company	0.03%	76,650	$1,992,000	—	31 Dec 2019	13F
Capital Impact Advisors, LLC	13F	Company	0.03%	75,418	$1,959,000	—	31 Dec 2019	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.03%	71,893	$1,868,000	—	31 Dec 2019	13F
AVIVA PLC	13F	Company	0.03%	68,910	$1,790,000	—	31 Dec 2019	13F
Russell Investments Group, Ltd.	13F	Company	0.02%	60,068	$1,559,000	—	31 Dec 2019	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.02%	58,930	$1,531,000	—	31 Dec 2019	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.02%	58,200	$1,512,000	—	31 Dec 2019	13F
TD ASSET MANAGEMENT INC	13F	Company	0.02%	57,875	$1,504,000	—	31 Dec 2019	13F
CITADEL ADVISORS LLC	13F	Company	0.02%	56,246	$1,461,000	—	31 Dec 2019	13F
Vident Investment Advisory, LLC	13F	Company	0.02%	56,070	$1,457,000	—	31 Dec 2019	13F
Squarepoint Ops LLC	13F	Company	0.02%	54,596	$1,418,000	—	31 Dec 2019	13F
RHUMBLINE ADVISERS	13F	Company	0.02%	53,224	$1,383,000	—	31 Dec 2019	13F

Institutional Holders of Allogene Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") (ALLO) as of Q1 2020

As of 31 Mar 2020, Allogene Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") (ALLO) was held by 115 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 73,747,853 shares. The largest 10 holders included TPG Group Holdings (SBS) Advisors, Inc., Capital Research Global Investors, BlackRock Inc., Capital International Investors, VANGUARD GROUP INC, FMR LLC, Capital World Investors, REGENTS OF THE UNIVERSITY OF CALIFORNIA, VV Manager LLC, and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 115 institutional shareholders reporting positions in this security for the Q1 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders

114

Q1 2020 holders

115

Holder diff

Investor	Q4 2019 Shares	Q1 2020 Shares	Share Diff	Share Chg %	Q4 2019 Value $	Q1 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.